Effects of zolpidem 10 mg, zopiclone 7.5 mg and flunitrazepam 1 mg on night-time motor activity

European Neuropsychopharmacology

Volumn 13, Issue 2, 2003, Pages 111-115

  Denise, P ^a   Bocca, M L ^b  

^a CHU CÔTE DE NACRE   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

Actigraphy; Flunitrazepam; Side effect; Sleep; Zolpidem; Zopiclone

Indexed keywords

FLUNITRAZEPAM; ZOLPIDEM; ZOPICLONE;

ACTIMETRY; ARTICLE; CLINICAL TRIAL; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; MOTOR ACTIVITY; NIGHT; NORMAL HUMAN; PRIORITY JOURNAL; SLEEP TIME; WAKEFULNESS;

EID: 0037337895     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-977X(02)00153-0     Document Type: Article

References (24)

1. Billiard M., Besset A., de Lustrac C., Brissaud L. Dose-response effects of zopiclone on night sleep and on night-time and daytime functioning. Sleep. 10:(Suppl. 1):1987;27-34.
2. Billiard M., Besset A., De Lustrac C., Brissaud L., Cadilhac J. Effects of zopiclone on sleep, daytime somnolence and nocturnal and daytime performance in healthy volunteers. Neurophysiol. Clin. 19:1989;131-143.
3. Borbély A.A. Ambulatory motor activity monitoring to study the timecourse of hypnotic action. Br. J. Clin. Pharmacol. 18:(Suppl 1):1984;83S-86S.
4. Borbély A.A. New techniques for the analysis of the human sleep-wake cycle. Brain Dev. 8:1986;482-488.
5. Borbély A.A., Loepfe M., Mattmann P., Tobler I. Midazolam and triazolam: hypnotic action and residual effects after a single bedtime dose. Arzneimittelforschung. 33:1983;1500-1502.
6. Borbély A.A., Mattmann P., Loepfe M. Hypnotic action and residual effects of a single bedtime dose of temazepam. Arzneimittelforschung. 34:1984;101-103.
7. Borbély A.A., Mattmann P., Loepfe M., Strauch I., Lehmann D. Effect of benzodiazepine hypnotics on all-night sleep EEG spectra. Hum. Neurobiol. 4:1985;189-194.
8. Brunner D.P., Dijk D.J., Münch M., Borbély A.A. Effects of zolpidem on sleep and sleep EEG spectra in healthy young men. Psychopharmacology. 104:1991;1-5.
9. Crowley T.J., Hydinger-Macdonald M. Bedtime flurazepam and the human circadian rhythm of spontaneous motility. Psychopharmacology. 62:1979;157-161.
10. Gaillard J.M., Blois R. Effect of the benzodiazepine antagonist Ro 15-1788 on flunitrazepam-induced sleep changes. Br. J. Clin. Pharmacol. 15:1983;529-536.
11. Gaillard J.M., Blois R. Differential effects of flunitrazepam on human sleep in combination with flumazenil. Sleep. 12:1989;120-132.
12. Gillin J.C., Spinweber C.L., Johnson L.C. Rebound insomnia: a critical review. J. Clin. Psychopharm. 9:1989;161-172.
13. Gimeno V., Sagales T., Miguel L., Ballarin M. The statistical distribution of wrist movements during sleep. Neuropsychobiology. 38:1998;108-112.
14. Jean-Louis G., Mendlowicz M.V., Gillin J.C., Rapaport M.H., Kelsoe J.R., Zizi F., Landolt H., von Gizycki H. Sleep estimation from wrist activity in patients with major depression. Physiol. Behav. 70:2000;49-53.
15. Mattmann P., Loepfe M., Scheitlin T., Schmidlin D., Gerne M., Strauch I., Lehmann D., Borbély A.A. Day-time residual effects and motor activity after three benzodiazepine hypnotics. Arzneimittelforschung. 32:1982;461-465.
16. Middelkoop H., Van Hilten B., Kramer C., Kamphuisen H. Actigraphically recorded motor activity and immobility across sleep cycles and stages in healthy male subjects. J. Sleep Res. 2:1993;28-33.
17. Nicholson A.N., Stone B.M. Activity of the hypnotics, flunitrazepam and triazolam, in man. Br. J. Clin. Pharmac. 9:1980;187-194.
18. Nicholson A.N., Stone B.M. Zopiclone: sleep and performance studies in healthy man. Int. Pharmacopsychiatry. 27:(Suppl 2):1982;92-97.
19. Nicholson A.N., Pascoe P.A. Hypnotic activity of an imidazo-pyridine (zolpidem). Br. J. Clin. Pharmacol. 21:1986;205-211.
20. Parrino L., Terzano M.G. Polysomnographic effects of hypnotic drugs. A review. Psychopharmacology. 126:1996;1-16.
21. Pilsworth S., King M., Shneerson J., Smith I. A comparison between measurements of sleep efficiency and sleep latency measured by polysomnography and wrist actigraphy. Sleep. 24:2001;A106.
22. Sadeh A., Hauri P.J., Kripke D.F., Lavie P. The role of actigraphy in the evaluation of sleep disorders. Sleep. 18:1995;288-302.
23. Sadeh A., Sharkey K.M., Carskadon M.A. Activity-based sleep-wake identification: an empirical test of methodological issues. Sleep. 17:1994;201-207.
24. Verbeek I., Klip E.C., Declerck A.C. The use of actigraphy revised: the value for clinical practice in insomnia. Percept Mot. Skills. 92:2001;852-856.